330 related articles for article (PubMed ID: 25701248)
1. Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis.
Huang XZ; Gao P; Sun JX; Song YX; Tsai CC; Liu J; Chen XW; Chen P; Xu HM; Wang ZN
Cancer Causes Control; 2015 Apr; 26(4):589-600. PubMed ID: 25701248
[TBL] [Abstract][Full Text] [Related]
2. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
3. Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.
Cronin-Fenton DP; Heide-Jørgensen U; Ahern TP; Lash TL; Christiansen P; Ejlertsen B; Sørensen HT
Epidemiology; 2016 Jul; 27(4):586-93. PubMed ID: 27007644
[TBL] [Abstract][Full Text] [Related]
4. Non-aspirin NSAID use and ovarian cancer mortality.
Verdoodt F; Dehlendorff C; Friis S; Kjaer SK
Gynecol Oncol; 2018 Aug; 150(2):331-337. PubMed ID: 29960709
[TBL] [Abstract][Full Text] [Related]
5. Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, acetaminophen and ovarian cancer survival.
Nagle CM; Ibiebele TI; DeFazio A; Protani MM; Webb PM;
Cancer Epidemiol; 2015 Apr; 39(2):196-9. PubMed ID: 25666512
[TBL] [Abstract][Full Text] [Related]
6. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
7. Do Aspirin and Other NSAIDs Confer a Survival Benefit in Men Diagnosed with Prostate Cancer? A Pooled Analysis of NIH-AARP and PLCO Cohorts.
Zhou CK; Daugherty SE; Liao LM; Freedman ND; Abnet CC; Pfeiffer R; Cook MB
Cancer Prev Res (Phila); 2017 Jul; 10(7):410-420. PubMed ID: 28507039
[TBL] [Abstract][Full Text] [Related]
8. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.
Liu Y; Chen JQ; Xie L; Wang J; Li T; He Y; Gao Y; Qin X; Li S
BMC Med; 2014 Mar; 12():55. PubMed ID: 24678716
[TBL] [Abstract][Full Text] [Related]
9. Aspirin and non-steroidal anti-inflammatory drugs use reduce gastric cancer risk: A dose-response meta-analysis.
Huang XZ; Chen Y; Wu J; Zhang X; Wu CC; Zhang CY; Sun SS; Chen WJ
Oncotarget; 2017 Jan; 8(3):4781-4795. PubMed ID: 27902474
[TBL] [Abstract][Full Text] [Related]
10. Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies.
Elwood PC; Morgan G; Pickering JE; Galante J; Weightman AL; Morris D; Kelson M; Dolwani S
PLoS One; 2016; 11(4):e0152402. PubMed ID: 27096951
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and risk of ovarian cancer: systematic review and meta-analysis of observational studies.
Baandrup L; Faber MT; Christensen J; Jensen A; Andersen KK; Friis S; Kjaer SK
Acta Obstet Gynecol Scand; 2013 Mar; 92(3):245-55. PubMed ID: 23240575
[TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin use on survival benefits of breast cancer patients: A meta-analysis.
Liu J; Zheng F; Yang M; Wu X; Liu A
Medicine (Baltimore); 2021 Aug; 100(33):e26870. PubMed ID: 34414938
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery.
Forget P; Machiels JP; Coulie PG; Berliere M; Poncelet AJ; Tombal B; Stainier A; Legrand C; Canon JL; Kremer Y; De Kock M
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S650-60. PubMed ID: 23884751
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.
Takkouche B; Regueira-Méndez C; Etminan M
J Natl Cancer Inst; 2008 Oct; 100(20):1439-47. PubMed ID: 18840819
[TBL] [Abstract][Full Text] [Related]
15. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
16. Pre-diagnostic aspirin use and mortality after breast cancer.
Wang T; Parada H; McClain KM; Bradshaw PT; Terry MB; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Causes Control; 2018 May; 29(4-5):417-425. PubMed ID: 29516320
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis.
Larsson SC; Giovannucci E; Bergkvist L; Wolk A
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2561-4. PubMed ID: 17164387
[TBL] [Abstract][Full Text] [Related]
18. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
Johnson TW; Anderson KE; Lazovich D; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
[TBL] [Abstract][Full Text] [Related]
19. Association of nonsteroidal anti-inflammatory drugs and aspirin use and the risk of head and neck cancers: a meta-analysis of observational studies.
Tang L; Hu H; Liu H; Jian C; Wang H; Huang J
Oncotarget; 2016 Oct; 7(40):65196-65207. PubMed ID: 27533449
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
Macfarlane TV; Murchie P; Watson MC
Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
